Dr. HENROTTE Isaline · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr. HENROTTE Isaline is 0.2% (very low). The 2024 annual accounts show equity of €156k and a net result of €120k. Its solvency ranks better than 68% of 6566 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Signals

1 signal · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2023 and 2024).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals

More than 3 years active

Founded in 2023, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.

Administratively compliant

No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€120k+257.8%

Working capital€156k+348.4%

CSV export

Annual accounts & ratios

Source: NBB · 2024

Annual accounts filed on 15-07-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	78.7%	66.7%	better than 68% of 6566 sector peers
Net result	€120k	€46k	better than 83% of 6560 sector peers
Equity	€156k	€79k	better than 72% of 6566 sector peers
Gross operating margin	€160k	€78k	better than 78% of 6568 sector peers
Total assets	€199k	€154k	better than 60% of 6569 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€157k

+269.0% +243% vs sector

Net profit

€120k

+257.8% far above sector median

Cash flow

€121k

+256.1% +212% vs sector

Total assets

€199k

+263.9% -65% vs sector

Equity

€156k

+333.1% -53% vs sector

Working capital

€156k

+348.4% -4% vs sector

Income taxes

€35k

+302.1% +159% vs sector

Debt

€42k

+128.6% -48% vs sector

Debt ≤ 1y

€42k

+128.6% -48% vs sector

Current ratio

4.69

+62.7% +15% vs sector

Quick ratio

4.69

+62.7% +15% vs sector

Solvency

78.7%

+19.0% +5% vs sector

Debt / equity

0.27

-47.2% -18% vs sector

ROE

76.9%

-17.4% far above sector median

ROA

60.6%

-1.7% far above sector median

Interest coverage

88.44

- +238% vs sector

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Revenue	-
EBITDA	€157k
Net profit	€120k
Cash flow	€121k
Staff costs	-
Income taxes	€35k
Dividends	-
Total assets	€199k
Equity	€156k
Debt	€42k
of which ≤ 1y	€42k
of which > 1y	-
Working capital	€156k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	4.69
Quick ratio	4.69
Working capital ratio	78.3%
Solvency	78.7%
Debt / equity	0.27
Long-term debt ratio	-
Interest coverage	88.44
Gross margin	-
Net margin	-
ROA	60.6%
ROE	76.9%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €834 · 0.4% Current assets €198k · 99.6%

Equity & liabilities

Equity €156k · 78.8% Debt €42k · 21.3%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€199k
Fixed assets	21/28	€834
Tangible fixed assets	22/27	€834
Current assets	29/58	€198k
Cash & bank	54/58	€110k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€199k
Equity	10/15	€156k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€154k
Amounts payable	17/49	€42k
Amounts payable within one year	42/48	€42k
Income statement
Gross operating margin	9900	€160k
Operating result	9901	€157k
Financial income	75	€268
Financial charges	65	€2k
Result before taxes	9903	€155k
Income taxes	67/77	€35k
Net result for the period	9904	€120k
Result to be appropriated	9905	€120k

You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2024 · computed

100 / 100 Excellent

050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →

Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location

Dr. HENROTTE Isaline

Quai de Rome 22, 4000 LiègeActiviteiten van medisch specialisten

since 20232.346.326.664

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area215 m²

Buildings1

Building footprint203 m²

Volume (LiDAR)6,559 m³

Tallest building38.7 m · ±11 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)